Inceptionr LLC Decreases Stake in IMAX Corporation $IMAX

Inceptionr LLC cut its stake in IMAX Corporation (NYSE:IMAX) by 71.6% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,425 shares of the company’s stock after selling 13,686 shares during the period. Inceptionr LLC’s holdings in IMAX were worth $206,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. Gibbs Wealth Management purchased a new stake in IMAX during the 1st quarter worth approximately $740,000. Sei Investments Co. raised its holdings in shares of IMAX by 37.8% in the first quarter. Sei Investments Co. now owns 185,045 shares of the company’s stock worth $7,033,000 after buying an additional 50,717 shares during the last quarter. State of Wyoming raised its holdings in shares of IMAX by 7.6% in the first quarter. State of Wyoming now owns 7,910 shares of the company’s stock worth $301,000 after buying an additional 562 shares during the last quarter. Cetera Investment Advisers acquired a new stake in shares of IMAX during the first quarter worth $418,000. Finally, Militia Capital Management LLC acquired a new stake in shares of IMAX during the first quarter worth $1,513,000. 93.51% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Record-setting IMAX demand: The Odyssey has generated approximately $140 million in global IMAX box office, helping demonstrate the revenue potential of high-profile films released in the format. The Odyssey reaches $140 million in global IMAX box office
• Positive Sentiment: Broad global rollout ahead: IMAX China is preparing to show the film on nearly 800 screens, with its chief executive citing the “Christopher Nolan effect.” The rollout could extend the film’s strong contribution to IMAX admissions and increase international visibility for the brand. IMAX China prepares full Odyssey rollout
• Positive Sentiment: Scarcity is amplifying consumer interest: Reports of sold-out or difficult-to-find 70mm IMAX tickets, audiences traveling long distances, and theaters drawing visitors from across Europe suggest unusually strong engagement. That buzz may support premium ticket pricing and encourage future filmmakers to use IMAX cameras. Why is it so hard to see The Odyssey in 70mm IMAX?
• Positive Sentiment: Potential long-term format benefit: Coverage examining whether directors beyond Nolan can shoot entirely with IMAX cameras highlights the company’s opportunity to expand premium-format adoption beyond a single blockbuster filmmaker. Can Anyone Other Than Christopher Nolan Shoot a Film Entirely on Imax?
• Neutral Sentiment: The publicity is concentrated around The Odyssey and its limited 70mm presentation. While this strengthens near-term sentiment, investors will need evidence that demand can persist through additional releases and justify IMAX’s elevated valuation.

Wall Street Analysts Forecast Growth

IMAX has been the topic of several research reports. Seaport Research Partners reissued a “buy” rating and issued a $50.00 target price on shares of IMAX in a research report on Wednesday, June 24th. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $42.00 price target on shares of IMAX in a research report on Thursday, July 23rd. Keefe, Bruyette & Woods reiterated a “market perform” rating and set a $60.00 price target on shares of IMAX in a research note on Friday, May 22nd. Weiss Ratings raised IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, July 16th. Finally, Wedbush raised their price objective on IMAX from $46.00 to $54.00 and gave the stock an “outperform” rating in a research note on Friday, July 24th. Ten analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $50.36.

IMAX Price Performance

IMAX stock opened at $47.18 on Wednesday. The company has a market capitalization of $2.59 billion, a P/E ratio of 65.53, a price-to-earnings-growth ratio of 1.65 and a beta of 0.37. IMAX Corporation has a 12 month low of $24.20 and a 12 month high of $47.31. The firm’s fifty day simple moving average is $40.49 and its 200-day simple moving average is $38.20.

IMAX (NYSE:IMAX) last issued its earnings results on Thursday, July 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.30 by $0.13. The firm had revenue of $102.84 million during the quarter, compared to analysts’ expectations of $96.09 million. IMAX had a net margin of 9.84% and a return on equity of 15.47%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.26 earnings per share. As a group, sell-side analysts forecast that IMAX Corporation will post 1.3 earnings per share for the current year.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.